Prevest Denpro Limited Reports Strong Q1 FY 2026-27 Performance

Prevest Denpro Limited, a leading dental products company, today announced its financial results for the quarter ended June 30, 2026. The Company delivered strong growth across key financial parameters, supported by continued business momentum and sustained demand across its product portfolio.

Note: All financial figures are stated in ₹ Lakhs, unless otherwise indicated.

"We are pleased to begin FY 2026-27 on a strong note, delivering healthy double-digit growth across our key financial parameters. Our consolidated Revenue from Operations grew 20.94% year-on-year, while EBITDA, PBT and PAT increased by 24.73%, 26.23% and 27.99%, respectively. The performance reflects the continued strength of our business fundamentals, growing acceptance of our dental product portfolio and our focus on operational efficiency. We remain committed to expanding our product offerings, strengthening our domestic and international presence and creating sustainable long-term value for our stakeholders. We remain optimistic about the year ahead and focused on driving sustainable growth through continued innovation, product development, operational excellence and expansion across domestic and international markets." - Mr. Atul Modi, Chairman and Managing Director.

KEY FINANCIAL HIGHLIGHTS

Standalone Results

- Revenue from Operations: grew 23.66% YoY to ₹1,944.33 lakh, compared to ₹1,572.27 lakh in Q1 FY 2025-26, and increased 2.85% QoQ from ₹1,890.40 lakh

- Total Income: grew 22.96% YoY to ₹2,077.40 lakh, compared to ₹1,689.53 lakh in Q1 FY 2025-26, and increased 2.00% QoQ from ₹2,036.66 lakh

- EBITDA: grew 22.60% YoY to ₹821.88 lakh, compared to ₹670.40 lakh in Q1 FY 2025-26

- PBT: grew 23.96% YoY to ₹770.26 lakh, compared to ₹621.38 lakh in Q1 FY 2025-26

- PAT: grew 24.77% YoY to ₹578.23 lakh, compared to ₹463.42 lakh in Q1 FY 2025-26

Consolidated Results

- Revenue from Operations: grew 20.94% YoY to ₹1,906.83 lakh, compared to ₹1,576.63 lakh in Q1 FY 2025-26, and increased 0.67% QoQ from ₹1,894.06 lakh

- Total Income: grew 20.38% YoY to ₹2,038.36 lakh, compared to ₹1,693.24 lakh in Q1 FY 2025-26, and increased 0.18% QoQ from ₹2,034.67 lakh

- EBITDA: grew 24.73% YoY to ₹808.14 lakh, compared to ₹647.93 lakh in Q1 FY 2025-26

- PBT: grew 26.23% YoY to ₹755.89 lakh, compared to ₹598.82 lakh in Q1 FY 2025-26

- PAT: grew 27.99% YoY to ₹563.86 lakh, compared to ₹440.54 lakh in Q1 FY 2025-26

The Board of Directors has recommended a dividend of 10% (₹1 per equity share) for FY 2025-26, subject to shareholder approval, as applicable.

Shares of Prevest Denpro Limited was last trading in BSE at Rs. 379.70 as compared to the previous close of Rs. 378.45. The total number of shares traded during the day was 15000 in over 39 trades.

The stock hit an intraday high of Rs. 387.75 and intraday low of 378.50. The net turnover during the day was Rs. 5728690.00.

Source : Equity Bulls

Keywords

PrevestDenpro INE0GAO01018 MedicalEquipment Q1FY27 Q1FY2027 ResultUpdate